AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Biosciences company enters collaboration to study genetics of heart disease.

Women's Health Weekly

| November 04, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 NOV 4 - (NewsRx.com & NewsRx.net) -- ParAllele BioScience announced that it has entered into collaboration with Novartis Pharma AG to discover genetic variations associated with coronary artery disease.

Coronary artery disease affects 13 million people in the United States and is the leading cause of death for both men and women. The results of the study will be used to identify biomarkers that can aid disease diagnosis and potentially guide treatment options, as well as identify and prioritize new drug targets.

In this Novartis-funded study, ParAllele will utilize its proprietary Mismatch Repair Detection (MRD) technology to comprehensively discover novel Single Nucleotide Polymorphisms (SNPs) in candidate genes selected by Novartis. These SNPs will be profiled across a large population of coronary artery disease patients and matched control samples to identify associations between SNPs and the disease. Novartis will utilize these markers in drug discovery and ParAllele will retain rights for diagnostic applications. Financial terms of the agreement were not disclosed.

"We are pleased to collaborate with Novartis in order to discover the key risk factors and causative mutations for coronary artery disease," said Nick Naclerio, PhD, ParAllele's President and CEO. "We hope our results will translate into earlier detection and better treatment options for this most common form ...

Related articles from newspapers, magazines, journals, and more
ParAllele BioScience Secures $22.5 Million in Financing; Funds to Support...
Press release article from: PR Newswire September 23, 2003 700+ words
...Calif., Sept. 23 /PRNewswire/ -- ParAllele BioScience, a privately held provider of genetic discovery...of the genetic basis of disease." About ParAllele Bioscience ParAllele BioScience is developing and commercializing new products...
ParAllele BioScience and Baylor Selected by NIH to Build the 'HapMap,' A New...
Press release article from: PR Newswire October 29, 2002 700+ words
...SAN FRANCISCO, Calif. -- ParAllele BioScience today announced that the...of the human genome. ParAllele BioScience and the Baylor College of...Researchers at Baylor will use ParAllele BioScience's Molecular Inversion Probe...
ParAllele BioScience Adds Andre Marion to the Company's Board of Directors;...
Press release article from: PR Newswire February 11, 2003 700+ words
...San Francisco, CA, February 11, 2002 - ParAllele BioScience, whose "lab in a tube"(TM) technologies...mechanical and electronic engineering. About ParAllele Bioscience ParAllele BioScience is developing and commercializing new products...
Roche and ParAllele BioScience Collaborate to Study Genetic Basis of Diabetes;...
Press release article from: PR Newswire September 16, 2003 700+ words
...Sept. 16 /PRNewswire/ -- Roche and ParAllele BioScience today announced a research collaboration...http://www.rocheusa.com/ About ParAllele Bioscience ParAllele BioScience is developing and commercializing new products...
ParAllele BioScience and Merck Collaborate to Discover Genetic Variations in...
Press release article from: PR Newswire May 12, 2004 700+ words
...FRANCISCO, Calif., May 12 /PRNewswire/ -- ParAllele BioScience, Inc. today announced a collaboration with...and the incidence of side effects. About ParAllele Bioscience ParAllele Bioscience is accelerating healthcare breakthroughs...
ParAllele BioScience and Baylor College of Medicine Announce Research...
Press release article from: PR Newswire July 29, 2003 700+ words
...FRANCISCO, Calif., July 29 /PRNewswire/ -- ParAllele BioScience today announced the initiation of a research...projects visit www.cardiogene.org. About ParAllele Bioscience ParAllele BioScience is developing and commercializing new products...
ParAllele BioScience and Merck to Collaborate on SNP Genotyping Study;...
Press release article from: PR Newswire July 9, 2003 700+ words
...FRANCISCO, Calif., July 9 /PRNewswire/ -- ParAllele BioScience today announced a collaboration with Merck...utilize our platform internally." About ParAllele Bioscience ParAllele BioScience is developing and commercializing new products...
ParAllele BioScience and Roche Demonstrate New Approach for Discovering...
Press release article from: PR Newswire May 18, 2004 700+ words
...May 18 /PRNewswire/ -- ParAllele BioScience, Inc., a provider of complete...Naclerio, President and CEO of ParAllele BioScience. "We look forward to applying...genotyping solutions. About ParAllele Bioscience ParAllele Bioscience, Inc...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA